The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-[(R)-3-(6-Hexyloxy-indol-1-yl)-1-hydroxymethyl-propyl]-1H-imidazole-4-carboxylic acid amide ID: ALA333809
PubChem CID: 11406877
Max Phase: Preclinical
Molecular Formula: C22H30N4O3
Molecular Weight: 398.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCOc1ccc2ccn(CC[C@H](CO)n3cnc(C(N)=O)c3)c2c1
Standard InChI: InChI=1S/C22H30N4O3/c1-2-3-4-5-12-29-19-7-6-17-8-10-25(21(17)13-19)11-9-18(15-27)26-14-20(22(23)28)24-16-26/h6-8,10,13-14,16,18,27H,2-5,9,11-12,15H2,1H3,(H2,23,28)/t18-/m1/s1
Standard InChI Key: ONWXFLCOAQGPAL-GOSISDBHSA-N
Molfile:
RDKit 2D
29 31 0 0 1 0 0 0 0 0999 V2000
4.6917 1.7833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5000 1.9583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3542 0.6250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6042 0.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5125 -1.0250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9042 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7042 -0.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0792 2.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6000 -1.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8417 -2.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2875 -1.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2875 -0.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1292 -0.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9125 -0.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5250 -0.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2917 2.0833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4625 -1.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2542 3.1458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4667 -0.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0542 -0.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0542 0.5750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9250 0.1125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3042 -0.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2292 0.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1833 1.2958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2458 2.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4208 2.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0083 1.2958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6583 2.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 4 1 0
4 1 2 0
5 13 1 0
6 2 2 0
7 5 1 0
8 1 1 0
9 5 1 0
10 9 2 0
11 7 1 0
12 7 2 0
13 14 1 0
14 15 1 0
15 3 1 1
16 8 2 0
17 11 2 0
18 8 1 0
19 12 1 0
20 19 2 0
21 19 1 0
22 23 1 0
23 15 1 0
24 21 1 0
25 24 1 0
26 27 1 0
27 28 1 0
28 25 1 0
29 26 1 0
3 6 1 0
11 10 1 0
17 20 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.51Molecular Weight (Monoisotopic): 398.2318AlogP: 3.52#Rotatable Bonds: 12Polar Surface Area: 95.30Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.82CX Basic pKa: 3.23CX LogP: 2.92CX LogD: 2.92Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.46Np Likeness Score: -0.68
References 1. Terasaka T, Kinoshita T, Kuno M, Seki N, Tanaka K, Nakanishi I.. (2004) Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors., 47 (15): [PMID:15239652 ] [10.1021/jm0306374 ]